Needham & Company LLC Issues Positive Forecast for Cognex (NASDAQ:CGNX) Stock Price

Cognex (NASDAQ:CGNX) had its price target boosted by analysts at Needham & Company LLC from $67.00 to $75.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has a “buy” rating on the scientific and technical instruments company’s stock. Needham & Company LLC’s price target suggests a potential upside of 13.42% from the company’s previous close.

A number of other equities research analysts have also recently weighed in on CGNX. UBS Group reiterated a “buy” rating and set a $70.00 price target on shares of Cognex in a research report on Friday, February 13th. Sanford C. Bernstein restated an “outperform” rating and issued a $75.00 price objective on shares of Cognex in a report on Thursday. DA Davidson set a $55.00 price objective on shares of Cognex and gave the company a “neutral” rating in a report on Tuesday, February 17th. Barclays lifted their price objective on shares of Cognex from $61.00 to $64.00 and gave the company an “overweight” rating in a report on Monday, March 16th. Finally, TD Cowen restated a “buy” rating on shares of Cognex in a report on Tuesday, February 17th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Cognex presently has an average rating of “Moderate Buy” and a consensus price target of $62.29.

Cognex Price Performance

Shares of CGNX opened at $66.13 on Friday. Cognex has a 1-year low of $28.56 and a 1-year high of $71.90. The stock has a market cap of $11.04 billion, a PE ratio of 78.72 and a beta of 1.48. The firm has a 50-day simple moving average of $52.67 and a two-hundred day simple moving average of $45.20.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share for the quarter, beating analysts’ consensus estimates of $0.25 by $0.09. Cognex had a net margin of 13.62% and a return on equity of 10.86%. The business had revenue of $268.44 million during the quarter, compared to analysts’ expectations of $245.98 million. During the same period last year, the business earned $0.14 earnings per share. The business’s revenue for the quarter was up 24.3% on a year-over-year basis. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. As a group, sell-side analysts expect that Cognex will post 0.97 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Robert Willett sold 177,052 shares of Cognex stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $58.39, for a total value of $10,338,066.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Angelos Papadimitriou sold 4,150 shares of Cognex stock in a transaction that occurred on Monday, February 23rd. The stock was sold at an average price of $55.58, for a total transaction of $230,657.00. Following the completion of the transaction, the director owned 16,222 shares of the company’s stock, valued at $901,618.76. This represents a 20.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 196,083 shares of company stock worth $11,419,321 over the last 90 days. 1.70% of the stock is owned by insiders.

Institutional Trading of Cognex

Several institutional investors have recently modified their holdings of the stock. Cassaday & Co Wealth Management LLC purchased a new stake in shares of Cognex during the 1st quarter worth approximately $36,000. Meeder Asset Management Inc. lifted its position in shares of Cognex by 63.2% during the 1st quarter. Meeder Asset Management Inc. now owns 2,132 shares of the scientific and technical instruments company’s stock worth $104,000 after buying an additional 826 shares during the last quarter. Parallel Advisors LLC lifted its position in shares of Cognex by 30.6% during the 1st quarter. Parallel Advisors LLC now owns 2,283 shares of the scientific and technical instruments company’s stock worth $112,000 after buying an additional 535 shares during the last quarter. California Public Employees Retirement System lifted its position in shares of Cognex by 1.3% during the 1st quarter. California Public Employees Retirement System now owns 326,961 shares of the scientific and technical instruments company’s stock worth $16,018,000 after buying an additional 4,256 shares during the last quarter. Finally, Financiere des Professionnels Fonds d investissement inc. lifted its position in shares of Cognex by 82.7% during the 1st quarter. Financiere des Professionnels Fonds d investissement inc. now owns 29,389 shares of the scientific and technical instruments company’s stock worth $1,440,000 after buying an additional 13,307 shares during the last quarter. Hedge funds and other institutional investors own 88.12% of the company’s stock.

Cognex News Summary

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Q1 results and upbeat Q2 guide — Cognex reported revenue of $268M (+24% YoY) and EPS $0.34, topping estimates, and issued Q2 revenue guidance of $280–$300M with EPS $0.40–$0.44, signaling continued growth and margin leverage. Cognex Reports First Quarter 2026 Results
• Positive Sentiment: Margin and profitability beat — gross margin expanded to ~71% and adjusted EBITDA margin improved materially, underscoring operating leverage that supports higher EPS power. Cognex Q1 Earnings and Revenues Top Estimates
• Positive Sentiment: AI product momentum highlighted on the call — management emphasized AI-led vision product launches and demand across broad end markets, which investors view as a durable growth driver. Cognex Earnings Call Highlights AI-Led Profit Surge
• Positive Sentiment: Analyst price-target upgrade — Stephens raised its price target to $75 and moved to overweight, giving formal Street support that can drive buy-side flows. Cognex Given New $75.00 Price Target at Stephens
• Positive Sentiment: Unusually heavy call activity — a large block of call option volume suggests short-term bullish positioning by traders/speculators ahead of/after the results. Cognex Q1 2026 Earnings Call Transcript
• Neutral Sentiment: Dividend announced — Cognex declared a $0.085 quarterly dividend (annualized ~0.5% yield), a modest income signal but not a material catalyst for stock rerating. Listen to Conference Call / Press Release
• Neutral Sentiment: Market commentary and stock momentum pieces question valuation after a big run — some articles debate whether further upside is warranted after substantial YTD/one?year gains; useful for investor context but not new company data. Is It Too Late To Consider Cognex (CGNX) After A 121% One Year Surge?
• Negative Sentiment: Recent insider selling and some institutional repositioning — public filings referenced notable insider sales and large portfolio moves that could weigh on sentiment if sustained. Cognex shares jump on Q1 beat and upbeat Q2 outlook

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.